Early revision rate in robotic-assisted versus conventional total knee arthroplasty: a prospective cohort study 2021–2023 from the Finnish Arthroplasty Register
No difference in all-cause revision risk was observed between rTKA and cTKA groups, however, within the first 12 months, fewer revisions due to PJI occurred in the rTKA group.
Abstract
Background and purpose Robotic-assisted total knee arthroplasty (rTKA) has been proposed to improve component positioning but evidence on its effect on implant survival is limited. We aimed to compare implant survival between rTKA and conventional total knee arthroplasty (cTKA) overall and due to peri-prosthetic joint infection (PJI). Methods We included all rTKAs performed in Finland from April 2021 until May 2023, all implanted with Triathlon TKA using MAKO robotic-arm assist. Propensity score matching was used to form a control group with similar characteristics for the same time period. Primary survival endpoint was first revision due to any cause within 12 months after the index surgery. PJI and non-PJI revisions were considered secondary outcomes. Kaplan–Meier (KM) analysis and Cox proportional hazards regression were used to assess implant survival and between-group contrasts hazard ratios (HR) with 95% confidence intervals (CIs), respectively. Results 1,318 fixed bearing rTKAs were compared with a control group of 1,318 cTKAs. Revision-free survival at 12 months after index surgery did not differ between groups. KM estimates were 99.1% (CI 98.5–99.7) for rTKA and 98.6% (CI 98.0–99.3) for cTKA with HR 0.61 (CI 0.28–1.34). The rTKA group demonstrated better PJI-free survival at 12 months (HR 0.29, CI 0.10–0.90). Overall, PJI was the most common reason for revision. At the end of available follow-up, the estimated overall survival was 97.7% (CI 94.9–100.0) for rTKA and 97.9% (CI 96.6–99.2) for cTKA. Conclusion No difference in all-cause revision risk was observed between rTKA and cTKA groups. However, within the first 12 months, fewer revisions due to PJI occurred in the rTKA group.
BACKGROUND
Total knee arthroplasty (TKA) is used for treatment of end-stage knee osteoarthritis (OA). Incidence of both OA and TKA is rising. Robot-assisted TKA (RA-TKA) is gaining popularity, the innovation is appealing to surgeons, hospitals and patients. Prior literature reports contrasting results: some suggesting...
M. C. Vink, R. J. M. Vossen, Rinne M. Peters et al.· Knee (Oxford)· 0 citations
RA-TKA was associated with a significantly lower rate of mechanical axis outliers and higher functional outcome scores at 12 months compared with manual TKA in patients with EAD, and the advantage may be most pronounced in severe and multiplanar deformities, but adequately powered studies are needed to confirm these fi...
G. Ayrapetov, D. Suleymanyants, I. Dmitrov et al.· Prosthesis· 0 citations
Abstract Objective To evaluate the early comparative effectiveness of robotic versus conventional total knee replacement (TKR) and unicompartmental knee replacement (UKR) in the UK. Design Target trial emulation study. Setting Public and private hospitals using data from the National Joint Registry of England, Wales, N...
H. Mohammad, Andrew Judge, Xavier L. Griffin et al.· British medical journal· 2 citations
ROSA® rTKA demonstrated satisfactory mid-term radiological outcomes, with accurate implant alignment and a low complication rate, and long-term comparative studies are needed to determine its superiority over conventional TKA techniques.
B. Alcobía-Díaz, R. García-Crespo, Laura Barragán-del Baño et al.· Journal of Robotic Surgery· 0 citations
Background and purpose Lateral knee replacement is not commonly performed. Possible explanations are the lower incidence of lateral knee osteoarthritis, relative technical complexity, and different biomechanics, which may affect failure modes and survival rates. We aimed to analyze the difference in risk of revision be...
Iris Koenraadt-van Oost, L. V. van Boekel, A. Hoorntje et al.· Acta Orthopaedica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.